Advertisement
Advertisement
PAHC
Phibro Animal Health Corporation Class A
40.00
USDSponsored
-3.16
-7.32%
May 08, 16:00 UTC -4
Closed
After-Market
41.08
+1.08
+2.70%
PAHC Earnings Reports
Positive Surprise Ratio
PAHC beat 26 of 41 last estimates.
63%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Phibro Animal Health Corporation Class A earnings per share and revenue
On May 06, 2026, PAHC reported earnings of 0.76 USD per share (EPS) for Q3 26, beating the estimate of 0.72 USD, resulting in a 4.50% surprise. Revenue reached 383.50 million, compared to an expected 374.36 million, with a 2.44% difference. The market reacted with a -26.22% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were Phibro Animal Health Corporation Class A's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Phibro Animal Health Corporation Class A reported EPS of $0.76, beating estimates by 4.5%, and revenue of $383.50M, 2.44% above expectations.
How did the market react to Phibro Animal Health Corporation Class A's Q3 2026 earnings?
The stock price moved down -26.22%, changed from $58.50 before the earnings release to $43.16 the day after.
When is Phibro Animal Health Corporation Class A expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Phibro Animal Health Corporation Class A's next earnings report?
Based on --
analysts, Phibro Animal Health Corporation Class A is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement